Ad
related to: are pacemakers expensive to produce- Patient Testimonials
Hear from our patients
about their Ohio State experience
- Prepare For Your Visit
What to bring to your visit
plus heart & vascular resources
- Find a Doctor
Meet with our experts to diagnose
your symptoms and receive treatment
- Should I See a Heart Doc
Talk to your doc about your heart
and learn what to ask
- Patient Testimonials
Search results
Results from the WOW.Com Content Network
A pacemaker, also known as an artificial cardiac pacemaker, is an implanted medical device that generates electrical pulses delivered by electrodes to one or more of the chambers of the heart. Each pulse causes the targeted chamber(s) to contract and pump blood, [ 3 ] thus regulating the function of the electrical conduction system of the heart .
It employs pacemaker cells that produce electrical impulses, known as cardiac action potentials, which control the rate of contraction of the cardiac muscle, that is, the heart rate. In most humans, these cells are concentrated in the sinoatrial (SA) node , the primary pacemaker, which regulates the heart’s sinus rhythm .
Cardiac Pacemaker's microlyth pacemaker. The company sold 8,500 pacemakers, increasing sales from zero in 1972 to over $47 million. In early 1978, CPI was concerned about a friendly takeover attempt. Despite impressive sales, the company's stock price had fluctuated wildly the year before, dropping from $33 to $11 per share.
At the time of acquisition, Telectronics was number 2 in the worldwide pacemaker market. [10] [11] [12] In January 1995, Telectronics was forced to recall thousands of model 801 atrial "J" leads by the Food and Drug Administration leading to the company having to eventually settle legal claims at a cost of hundreds of millions of dollars. [13]
The biological pacemaker is intended as an alternative to the artificial cardiac pacemaker that has been in human use since the late 1950s. Despite their success, several limitations and problems with artificial pacemakers have emerged during the past decades such as electrode fracture or damage to insulation , infection , re-operations for ...
The 10 stocks that made the cut could produce monster returns in the coming years. ... low heart rate that led to a necessary pacemaker. And there are so many touching notes around the profound ...
On September 22, Guidant issued safety advisories and recalls for 170,000 of their pacemakers, 56% of their total pacemakers. On October 18, Johnson & Johnson gave an announcement that they were exploring alternatives to the acquisition, followed by a November 2 warning that they might pull out of the deal due to the regulatory issues and legal ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Ad
related to: are pacemakers expensive to produce